Studying the safe and effective use of Modigraf (a tacrolimus-containing medicine in the form of granules that can be suspended in fluid) to prevent rejection of transplants in children

Update Il y a 4 ans
Reference: EUCTR2009-012259-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

F506-CL-0404A: To monitor the safety and efficacy of Modigraf® (tacrolimus granules) in stable paediatric allograft recipients. F506-CL-0404B: To monitor dose changes and tacrolimus whole blood trough levels after conversion from a Modigraf® based Immunosuppression regimen to a Prograf® based Immunosuppression regimen.


Inclusion criteria

  • Stable paediatric allograft recipients